Political pressure on examiners is no way to reform India's patent system

The battle over the Indian patent sought by Gilead Sciences for its Hepatitis C drug Sofosbuvir (branded Sovaldi) seemingly came to a conclusion last week when the country's patent office reversed course to grant the US drug maker protection for…

Get unlimited access to all IAM content